1. ICER says AbbVie’s Rinvoq for RA may be cost-effective but still questions the value of JAK class — Gilead, Galapagos share 52-week update on filgotinib — UPS gets clearance to expand medical drone delivery service across US — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Layoffs? Acquisition?

Discussion in 'Promius Pharma' started by anonymous, Mar 21, 2019 at 9:24 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    its over people. Now it’s just about the details.
     
  2. anonymous

    anonymous Guest

    ????